HM2018-32 A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of LoncastuximabTesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

  • Maakaron, Joseph (PI)
  • Janakiram, Murali (Prior Principal Investigator)
  • Pongas, Georgios (Prior Principal Investigator)

Project: Research project

Project Details

Description

HM2018-32 A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of Loncastuximab Tesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
StatusFinished
Effective start/end date11/1/18 → 4/30/23

Funding

  • ADC THERAPEUTICS SA

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint